A 12-month, open-label, repeat-dose safety study of Valtoco ™ (NRL-1, diazepam nasal spray) in patients with epilepsy: Interim report

Authors

• Michael Sperling

Publication/Presentation Date

4-2019

Volume

92

Issue

15

Published In/Presented At

https://doi.org/10.1212/WNL.92.15_supplement.P1.5-028

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine

Document Type

Article